In the ongoing battle of BYOD (bring-your-own-device) vs. provision devices, Zachary Javitt, CEO and co-founder of PillTracker, has firmly come down on one side.
Topics: Pharma15, clinical research, clinical trials, Disruptive Innovation, Conferences, digital
On Saturday November 3, BBK will be hosting the American Brain Tumor Association’s (ABTA) Boston regional meeting and resource fair at its offices in Needham, Mass. Founded in 1973, ABTA was the first national advocacy organization committed to funding brain tumor research and providing information and education to patients, caregivers, and their loved ones.
For 45 years, ABTA has been providing comprehensive resources that support the complex needs of brain tumor patients and caregivers, as well as the critical funding of research in the pursuit of breakthroughs in brain tumor diagnosis, treatment and care. In anticipation of the upcoming meeting in Boston, we spoke with ABTA Program Manager Christine Daly about the organization and their mission.
|
The first time I met Christine Pierre, we argued.
|
Pharma15 Live! sat down with David Levesque to discuss the goal and mission of Andaman7. Throughout the DPharm, one of the main topics was about new ways to allow patients to access their own data.
Topics: Pharma15, clinical research, clinical trials, Disruptive Innovation, Conferences, digital
You might have seen an article in the October 1 issue of The New York Times, titled “Uber, Lyft and the Urgency of Saving Money on Ambulances,” by Austin Frakt. The article pushed for alternative modes of transportation in medical situations – such as Uber and Lyft – as cost-saving measures.
CEO and Founding Principal of BBK Worldwide, Joan F. Bachenheimer, wrote a strong response to the article, which has been submitted to the Times as a Letter to the Editor. We would love to hear your thoughts on possible use of ride-sharing apps like Uber or Lyft for emergency services.
Topics: Patient Experience, Patient Engagement, Patient Retention, Patient Travel
Pharma15 Live! sat down Valerie Bowling, drug development industry researcher and founder of DPharm, during the conference to discuss this year’s presentations, and the very popular DPharm Idol competition:
Topics: Pharma15, clinical research, clinical trials, Patient Data, Disruptive Innovation, Conferences
What does patient data ownership actually mean? According to Craig Lipset, head of clinical innovation at Pfizer and DPharm 2018 co-chair, that is still an open question. Pharma15 Live! chatted with him about it at the DPharm 2018 conference.
Topics: Pharma15, Patient Experience, clinical research, clinical trials, Patient Data, Disruptive Innovation, Conferences, Most Viewed
We are very excited to announce that our next Pharma15 Live! event will be held in conjunction with the 8th annual DPharm: Disruptive Innovations conference in Boston, September 25-26.
Topics: Conferences, Disruptive Innovation
We sat down with drug development industry researcher Valerie Bowling, a veteran conference director who covers the clinical trials market, to discuss her views on R&D trends and challenges and why she launched DPharm, a disruptive thinking conference for clinical trials (held this year in Boston, September 25-26).
Topics: Conferences, Disruptive Innovation, clinical research
Experts across the healthcare industry agree that patients should be able to easily access their medical data. While this sentiment is shared among key industry stakeholders, the ideas of “consumer centricity”, and how researchers specifically stand to benefit from delivering patient data, are popular talking points among experts in our industry.
Topics: Patient Data, clinical research, clinical trials, Pharma15
She forcefully made the point that research sites were the most critical players in the clinical research enterprise. No sponsor could conduct quality research without quality investigators.